The market has stayed flat over the past 7 days but is up 34% over the past year, with earnings expected to grow by 15% per annum over the next few years. In this thriving environment, identifying promising small-cap stocks like SBC Medical Group Holdings can offer significant opportunities for investors seeking to uncover hidden gems.
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
Morris State Bancshares | 10.20% | -0.28% | 6.97% | ★★★★★★ |
Teekay | NA | -6.48% | 55.79% | ★★★★★★ |
Mission Bancorp | 25.37% | 16.23% | 20.16% | ★★★★★★ |
Omega Flex | NA | 1.31% | 3.88% | ★★★★★★ |
First Northern Community Bancorp | NA | 7.12% | 10.04% | ★★★★★★ |
Banco Latinoamericano de Comercio Exterior S. A | 311.64% | 21.07% | 24.77% | ★★★★★☆ |
United Bancorporation of Alabama | 13.34% | 18.86% | 25.45% | ★★★★★☆ |
San Juan Basin Royalty Trust | NA | 33.61% | 35.00% | ★★★★★☆ |
Valhi | 38.71% | 2.57% | -19.76% | ★★★★★☆ |
FRMO | 0.17% | 12.99% | 23.62% | ★★★★☆☆ |
Click here to see the full list of 211 stocks from our US Undiscovered Gems With Strong Fundamentals screener.
We'll examine a selection from our screener results.
Simply Wall St Value Rating: ★★★★★☆
Overview: SBC Medical Group Holdings Incorporated offers management services to cosmetic treatment centers in Japan, Vietnam, and internationally with a market cap of $802.92 million.
Operations: SBC Medical Group Holdings generates revenue primarily from its healthcare facilities and services segment, totaling $217.54 million.
SBC Medical Group Holdings, a small cap company, has shown impressive earnings growth of 164% over the past year, outpacing the healthcare industry's 8%. Trading at 92.9% below its estimated fair value and having more cash than total debt suggests strong financial health. Despite high volatility in share price recently, SBC was added to the NASDAQ Composite Index on September 20, 2024. However, shareholders have faced substantial dilution in the past year.
Gain insights into SBC Medical Group Holdings' historical performance by reviewing our past performance report.
Simply Wall St Value Rating: ★★★★★☆
Overview: Centrus Energy Corp. supplies nuclear fuel components and services for the nuclear power industry in the United States, Belgium, Japan, and internationally with a market cap of $892.95 million.
Operations: Centrus Energy generates revenue primarily from its Low-Enriched Uranium (LEU) segment, which accounts for $320.80 million, and its Technical Solutions segment, contributing $71.80 million.
Centrus Energy, a small-cap company, has shown impressive growth with earnings up 164.9% over the past year, outpacing the Oil and Gas sector's -32.9%. Trading at 63.4% below its estimated fair value, it appears to be undervalued. Despite significant insider selling in recent months, Centrus remains profitable with more cash than total debt and positive free cash flow. Recent appointments to its Board aim to bolster strategic initiatives and governance.
Review our historical performance report to gain insights into Centrus Energy's's past performance.
Simply Wall St Value Rating: ★★★★★★
Overview: Yiren Digital Ltd. provides financial services through an AI-powered platform in China and has a market cap of $494.66 million.
Operations: Yiren Digital Ltd. generates revenue primarily from its Financial Services Business (CN¥3.04 billion) and Insurance Brokerage Business (CN¥579.22 million), with additional contributions from its Consumption & Lifestyle Business (CN¥1.84 billion).
Yiren Digital, a small cap player in the consumer finance sector, has shown robust performance with earnings growth of 18.2% over the past year, outpacing the industry average of -8.4%. Trading at 79.2% below its estimated fair value, it presents an attractive valuation. The company repurchased 815,522 shares for $4 million recently and announced a semi-annual dividend policy with an initial payment of $0.20 per ADS expected on October 15, 2024.
Evaluate Yiren Digital's historical performance by accessing our past performance report.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGM:SBC NYSEAM:LEU and NYSE:YRD.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.